Key facts
- NurExone Biologic reported GAAP EPS of -$0.03.
NurExone Biologic has announced its financial results, reporting a GAAP earnings per share of -$0.03. This figure is a key financial metric for the company.
NurExone Biologic announced its financial results, reporting a GAAP earnings per share of -$0.03. This figure is a key financial metric for the company.
NurExone Biologic has announced its financial results, reporting a GAAP earnings per share of -$0.03. This figure is a key financial metric for the company.
This report provides insight into the company's profitability and financial performance.